Leveraging Science Communication Tools to Craft Effective Health Messages

LIVEFace to FaceDHPAMA

Add to Calendar Leveraging Science Communication Tools to Craft Effective Health Messages 10/22/2022 9:00:00 AM 10/23/2022 4:15:00 PM Asia/Riyadh Weill Cornell Medicine-Qatar false MM/DD/YYYY


Date & Location
Saturday, October 22, 2022, 9:00 AM - Sunday, October 23, 2022, 4:15 PM, Weill Cornell Medicine-Qatar, Doha, Qatar

Overview

This 2 day course on October 22-23, 2022 will investigate how the art of communicating science impacts public engagement with health messages at both the individual and population level. Participants will explore the basic principles of science communication, how science literacy impacts health behaviors and understanding of scientific evidence, methods to identify and pre-bunk misinformation when it arises, and how to effectively create evidence-informed health messages for different audiences and platforms. In addition, we will also explore how the scientific process, human cognition, and various social factors contribute to the public’s willingness to engage in scientific/health discussions.

Please refer to the 'Schedule' tab for the detailed program


Target Audience
Specialties - Allied Health Professionals, Dentists, Educators, Nurses, Pharmacists, Physicians


Objectives
  1. 1. Define scientific communication, how it is impacted by science and health literacy, and where it can go wrong.
  2. 2. Explain how cognitive processes influence how information is received and internalized.
  3. 3. Describe techniques for developing and testing messages for different audiences.
  4. 4. Create an online communication proposal tailored to a particular audience.

Registration

QAR 200 or $55

The registration closes ONE day before the activity.

Changes or Cancellations

  • Name changes or substitutions are not permitted.
  • All cancellation and refund requests must be made in writing and submitted via email to [email protected].
  • For a full refund of the registration fee, the cancellation request must be received at least 7 days prior to the session. No refund will be offered for cancellation request thereafter.
  • We will attempt to process the refund within 30 days of receiving any cancellation request.
  • Weill Cornell Medicine-Qatar reserves the right to cancel the course. In the event of a cancellation, fee deposit will be returned, but we will not be responsible for any other expenses including restricted or non-refundable airfare or hotel deposits.


Accreditation
 

Weill Cornell Medicine-Qatar is accredited as a provider of Continuing Medical Education (CME) and Continuing Professional Development (CPD) by the Department of Healthcare Professions (DHP) of the Ministry of Public Health.

This activity is an Accredited Group Learning Activity (Category 1) as defined by the Ministry of Public Health's Department of Healthcare Professions -Accreditation Section and is approved for a maximum of 9.75 hours. 

  
 

The Weill Cornell Medicine Qatar is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

 The Weill Cornell Medicine-Qatar designates this live activity for a maximum of 9.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

 Disclosure of Relationships/Content Validity

It is the policy of Weill Cornell Medicine-Qatar to adhere to Ministry of Public Health's Department of Healthcare Professions (DHP) and Accreditation Council for Continuing Medical Education (ACCME) Criteria, Policies, and Standards for Commercial Support and content validation in order to ensure fair balance, independence, objectivity, and scientific rigor in all its sponsored programs. All faculty participating in sponsored programs are expected to disclose relevant financial relationships pertaining to their contribution to the activity, and any discussions of off-label or investigational uses of approved commercial products or devices, or of any products or devices not yet approved in the United States and elsewhere. WCM-Q CME/CPD activities are intended to be evidence-based and free of commercial bias. 

Scientific Planning Committee: Phyllis Sui Muffuh Navti, DHSci, Constantina Dalassou, MDS, Moune Jabre, MD, Ioana Valea, PhD, Mark D. Santos, RN, Aisha Javaid, BSc,  Paul McDermott, MSc, Nurul Mansor, MLIS

Have no relevant financial relationship to disclose

Will not be discussing any unlabeled/unapproved use of drugs or products

Course Director/Faculty: Jamie Gray, MLS

Has disclosed the following financial relationships:
  • Proctor and Gamble (Stock Shareholder)
  • Colgate-Palmolive (Stock Shareholder)

The financial relationships are not relevant.

 Will not be discussing unlabeled/unapproved use of drugs or products

Independent Clinical Reviewer (ICR): Deema Al-Sheikhly, MEHP

Has no relevant financial relationship to disclose

 Will not be discussing any unlabeled/unapproved use of drugs or products

Co-Course Director: Ross MacDonald, PhD

Has no relevant financial relationship to disclose

Will not be discussing any unlabeled/unapproved use of drugs or products 

Course Faculty: Maya Adam, MD, Sinead O'Rourke, MSc, Javaid Sheikh, MD

Has no relevant financial relationship to disclose

Will not be discussing any unlabeled/unapproved use of drugs or products

Administrator: Ms. Kamala Rajendran

 Has no relevant financial relationship to disclose

Will not be discussing any unlabeled/unapproved use of drugs or products

The scientific planning committee has reviewed all disclosed financial relationships of speakers, moderators, facilitators and/or authors in advance of this CPD activity and has implemented procedures to manage any potential or real conflicts of interest